Research Interest

HIV/AIDS and health disparities and health outcomes research by optimizing medication use for minority, underserved, and international populations.

Profile

Christine Oramasionwu is an assistant professor in the Division of Pharmaceutical Outcomes and Policy. Her research interests are in the areas of HIV/AIDS, health outcomes, and health disparities in minority, underserved, and international populations.

She is now embarking on projects that focus on medication-use patterns, barriers to treatment, and comorbid conditions in patients with HIV/AIDS. For example, she recently submitted a grant proposal that seeks to assess how a patient’s race and ethnicity influences barriers to receiving hepatitis C therapy among HIV patients who are infected with the hepatitis C virus. The results of this pilot study will serve as preliminary data for future studies that will assess how barriers to therapy change for co-infected minority patients as newer medications for hepatitis C infection become available. The intent of Oramasionwu's research is to develop interventions that improve access to therapy for these patients. The National Institutes of Health/National Institute on Minority Health and Health Disparities Loan Repayment Program has funded Oramasionwu’s research endeavors.

She received her doctor of pharmacy, master of science, and doctor of philosophy from the University of Texas at Austin College of Pharmacy, and she has completed specialty residency training and is a board certified pharmacotherapy specialist. She is a member of the American College of Clinical Pharmacy, the Infectious Diseases Society of America, and the International Society for Pharmacoeconomics and Outcomes Research.